{"id":"W2525261975","doi":"10.1200/jco.2015.33.3_suppl.276","title":"Baseline demographics of the randomized, placebo-controlled, double-blind, phase III RADIANT-4 study of everolimus in nonfunctional gastrointestinal (GI) or lung neuroendocrine tumors (NET).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Everolimus; Medicine; Clinical endpoint; Neuroendocrine tumors; Internal medicine; Placebo; Concomitant; Randomized controlled trial; Gastroenterology; Progression-free survival; Oncology; Surgery; Pathology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00280254,0.001579074,0.002128368,0.0005091808,0.0008408938,0.0008819691,0.0005705074,0.001319168,0.01714624],"category_scores_gemma":[0.0022164,0.0006428436,0.0009095537,0.0007166581,0.000654216,0.001144456,0.000291392,0.002274944,0.002773953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007969809,"about_ca_system_score_gemma":0.001852311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007662022,"about_ca_topic_score_gemma":0.00144313,"domain_scores_codex":[0.9987141,0.0004252869,0.0001510085,0.0002900438,0.0001742182,0.0002454926],"domain_scores_gemma":[0.9988031,0.0002487834,0.0002549954,0.00006982271,0.0001497619,0.0004733774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8993256,0.01235028,0.02746882,0.001282191,0.001678127,0.0003069775,0.0001643756,0.0009195748,0.00806793,0.0003778312,0.01292671,0.03513164],"study_design_scores_gemma":[0.6117504,0.1918519,0.1506803,0.0003194606,0.00260159,0.0006665196,0.0001934075,0.001245552,0.00223584,0.001102542,0.03721177,0.0001407726],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8365039,0.01471016,0.003050244,0.001734878,0.000857059,0.05231414,0.0685907,0.0003202169,0.02191878],"genre_scores_gemma":[0.8651488,0.004316037,0.003621231,0.00394177,0.000425652,0.07815264,0.02980458,0.0000790705,0.01451021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01714624,"threshold_uncertainty_score":0.05735987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.143919802945755,"score_gpt":0.4773111673000061,"score_spread":0.3333913643542512,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}